期刊文献+

高效液相荧光色谱法测定人血浆中唑吡坦的浓度 被引量:1

Determination of Zolpidem in Human Plasma by HPLC with Fluorescence
下载PDF
导出
摘要 目的:建立测定人血浆中唑吡坦浓度的高效液相荧光色谱法。方法:血浆样品经甲醇沉淀后,以甲醇-1%醋酸液(40:60)为流动相,流速为0.3 ml·min^(-1),色谱柱为Agilent Zorbax C_(18)(150 mm×3 mm,3.5μm),柱温为22℃,荧光检测波长:激发波长(λex)254 nm,发射波长(λem)390 nm。结果:血浆内源性杂质不干扰待测物测定,唑吡坦的线性范围为2~300μg·L^(-1),定量下限为2μg·L^(-1),日内、日间RSD均<5%。样品经3次冻融及再沉淀后,4℃下6 h内稳定性良好。结论:该法灵敏、快速、准确,操作简便,线性范围宽,可用于唑吡坦的临床药动学研究。 Objective: To establish an HPLC with fluorescence method for determination of Zolpidem in human plasma. Method: Plasma samples were treated by methanol. The Agilent Zorbax C18 column (150 mm × 3 mm,3.5μm) at 22℃ was used. The mobile phase consisted of methanol: 1% acetic acid (40: 60) pumped at a flow rate of 0.3 ml· min^-1. The fluorescence detector was opreated at an excitation and emission wavelengths 254 nm and 390 nm, respectively. Result: The intrinsic impurity of plasma did not interfere with the determination of analyte. The linear range of Zolpidem was 2 -300μg· L^-1. Lower limit of quantification was 2μg· L^-1. The precision of inter-day were less than 5%. The stability of unprocessed and processed samples stored at 4 ℃ for 6 hours was good. After 3 cycles of freeze and thaw processes, the plasma samples were stable. Conclusion: The established HPLC-FLU method is fast, sensitive, and accurate and can be applied to the clinical pharmaeokinetics investigations of Zolpidem.
出处 《中国药师》 CAS 2009年第3期304-306,共3页 China Pharmacist
关键词 唑吡坦 高效液相色谱法 血药浓度 Zolpidem HPLC Drug concentration in plasma
  • 相关文献

参考文献6

二级参考文献29

  • 1费叶,余艳芳.唑吡坦引起精神症状不良反应1例[J].药物流行病学杂志,2004,13(5):278-279. 被引量:4
  • 2Wang Q, Sun L, Lau CE. Determination of zolpidem in serum microsamples by high-performance liquid chromatography and its application to pharmacokinetics in rats [ J]. J Chromatogr B Biomed Sci Appl, 1999,734(2) :299 - 305.
  • 3Durol AL, Greenblatt DJ. Analysis of zolpidem in human plasma by high-performance liquid chromatography with fluorescence detection:application to single-dose pharmacokinetic studies [ J ]. J Anal Toxlcol, 1997,21(5) :388 - 392.
  • 4Plaeek P, Macek J, Klima J. Rapid and simple method for the determination of zolpidem in human plasma by high-performance liquid chromatography[J]. J Chromatogr B Biomed Sci Appl , 1997,694(2) :409 - 413.
  • 5Olubodun JO, Ochs HR, Truten V. Zolpidem pharmacokinetic properties in young females: influence of smoking and oral contraceptive use [ J ]. J Clin Pharmacol, 2002,42 ( 10 ) : 1142 -1146.
  • 6Salva P, Costa J. Clinical pharmacokinetics and pharmacodynamics of zolpidem. Therapeutic implications[J]. Clin Pharmacokinet, 1995,29(3) : 142- 153.
  • 7Olubodun JO, Oehs HR, yon Mohke LL. Pharmaeokinetie properties of zolpidem in elderly and young adults: possible modulation by testosterone in men [ J ]. Br J Clin Pharmacol, 2003,56 ( 3 ) : 297 -304.
  • 8Hesse LM, yon Mohke LL, Greenblatt DJ. Clinically important drug interactions with zopiclone, zolpidem and zaleplon [ J ]. CNS Drugs,2003,17(7) :513 - 532.
  • 9RING PR,BOSTICK JM.Validation of a method for the determination of zolpidem in human plasma using LC with fluorescence detection[J].J Pharm Biomed Anal,2000,22(3):495-504.
  • 10LAVIANA L,MANGAS C,FERNANDEZ-MARl F,et al.Determ ination and in-process control of zolpidem synthesis by high-performance liquid chromatography[J].J Pharm Biomed Anal,2004,36 (4):925 -928.

共引文献20

同被引文献5

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部